KANGEN - Key Persons

Job Titles:

• Executive Vice President, Development for Kangen Pharmaceuticals America

Aidan Nuttall Ph.D. is the Executive Vice President, Development for Kangen Pharmaceuticals America, LLC. Dr. Nuttall has over 35 years of pharmaceutical development with expertise in the oversight of preclinical and clinical evaluations. Previously, Dr. Nuttall held senior positions in pharma, biotech and CRO companies in the United States and Europe, working across a wide spectrum of therapeutic areas. Aidan was previously the Executive VP, Development for KC Specialty Therapeutics, LLC.

Job Titles:

• President of Kangen Pharmaceuticals, Co

Diana Wood is the President of Kangen Pharmaceuticals, Co. Ltd., as well as CEO of Kangen Pharmaceuticals America, LLC. Diana has over 35 years of global experience in the development of pharmaceuticals, biologics and devices, with a specialization in treatments for rare diseases. Diana has spent the last 25 years working as an early employee of 8 various start-up companies successfully acquiring capital to complete development, that were eventually acquired. Diana is an accomplished author, lecturer and patent holder. Diana was previously the CEO of KC Specialty Therapeutics, LLC and the VP, Corporate Development for Stason Pharmaceuticals, Inc.